Sage Therapeutics to Present at the Stifel 2022 Healthcare Conference
November 09 2022 - 6:30AM
Business Wire
Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical
company leading the way to create a world with better brain health,
announced today that the Company will present at the Stifel 2022
Healthcare Conference on Wednesday, November 16, 2022, at 10:55
a.m. ET in New York, NY.
A live webcast of the presentation can be accessed on the
Investor page of Sage’s website at investor.sagerx.com. A replay of
the webcast will be available following the completion of the event
and will be archived for up to 30 days.
About Sage Therapeutics Sage Therapeutics is a
biopharmaceutical company fearlessly leading the way to create a
world with better brain health. Our mission is to pioneer solutions
to deliver life-changing brain health medicines, so every person
can thrive. For more information, please visit. www.sagerx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221109005349/en/
Investors Helen Rubinstein 315-382-3979
helen.rubinstein@sagerx.com
Media Matthew Henson 917-930-7147
matthew.henson@sagerx.com
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Apr 2023 to Apr 2024